RHIEOS is a consulting and venture development company focused on clinical r&D, enabling access to healthcare & learning

Rhieos-Ventures was founded in 2013 by Larry Ajuwon, a seasoned consultant who has supported the development and launch of new treatments in several therapeutic areas including CNS, Oncology, Anti-infectives, Organ Transplant, Cardiovascular, Genetic disorders in various roles and functions, across all geographies. He brings more than 24 years of industry experience to the table.  

A strong advocate for patient access, global health and neglected disease solutions, Larry actively supports projects and initiatives to develop better solutions for underserved patient groups. He helped found the first multi-centre sickle cell disorder registry in Nigeria and continues to strive to improve the clinical research-to-care enterprise.  

Before biopharma/healthcare, Larry worked as an assay/analytical scientist in food/beverage, chemical and motion picture companies.  

RHIEOS Ventures is the corporate trustee for Afrelib Trust, a charitable entity focused on advancing education, literacy and building sustainable libraries in Africa.